| Primary |
| Drug Use For Unknown Indication |
35.4% |
| Multiple Allergies |
14.7% |
| Rhinitis Allergic |
10.9% |
| Product Used For Unknown Indication |
9.2% |
| Sinus Disorder |
4.5% |
| Sinusitis |
4.5% |
| Nasal Congestion |
3.5% |
| Seasonal Allergy |
2.4% |
| Asthma |
1.9% |
| Postnasal Drip |
1.9% |
| Hypersensitivity |
1.7% |
| Rhinitis |
1.6% |
| Sinus Congestion |
1.6% |
| Cough |
1.4% |
| Chronic Sinusitis |
1.0% |
| Ill-defined Disorder |
0.9% |
| Rhinorrhoea |
0.9% |
| Allergic Sinusitis |
0.7% |
| Hypertension |
0.7% |
| Upper-airway Cough Syndrome |
0.7% |
|
| Epistaxis |
17.0% |
| Product Quality Issue |
12.5% |
| Drug Ineffective |
12.3% |
| Headache |
7.1% |
| Vision Blurred |
4.9% |
| Sinusitis |
4.7% |
| Nasal Ulcer |
4.5% |
| Pharmaceutical Product Complaint |
4.5% |
| Nasal Discomfort |
3.8% |
| Anosmia |
3.4% |
| Rash |
3.0% |
| Nasal Dryness |
2.8% |
| Rhinorrhoea |
2.8% |
| Sneezing |
2.6% |
| Urticaria |
2.6% |
| Cataract |
2.4% |
| Dizziness |
2.4% |
| Nausea |
2.4% |
| Overdose |
2.4% |
| Therapeutic Response Unexpected |
2.2% |
|
| Secondary |
| Product Used For Unknown Indication |
17.1% |
| Asthma |
14.5% |
| Rhinitis Allergic |
12.5% |
| Sinusitis |
10.5% |
| Drug Use For Unknown Indication |
9.9% |
| Multiple Allergies |
4.6% |
| Nasal Congestion |
4.6% |
| Depression |
3.3% |
| Dyspnoea |
2.6% |
| Ill-defined Disorder |
2.6% |
| Nasal Inflammation |
2.6% |
| Smoking Cessation Therapy |
2.6% |
| Anxiety |
2.0% |
| Chronic Obstructive Pulmonary Disease |
2.0% |
| Restless Legs Syndrome |
2.0% |
| Chronic Sinusitis |
1.3% |
| Nasal Obstruction |
1.3% |
| Pneumonia |
1.3% |
| Rhinorrhoea |
1.3% |
| Sinus Disorder |
1.3% |
|
| Drug Ineffective |
17.5% |
| Pneumonitis Chemical |
10.0% |
| Product Quality Issue |
10.0% |
| Urticaria |
7.5% |
| Death |
5.0% |
| Dyspnoea |
5.0% |
| Epistaxis |
5.0% |
| Rhinorrhoea |
5.0% |
| Sneezing |
5.0% |
| Therapeutic Response Unexpected |
5.0% |
| Acne |
2.5% |
| Adverse Event |
2.5% |
| Anosmia |
2.5% |
| Anxiety |
2.5% |
| Asthma |
2.5% |
| Breast Cancer |
2.5% |
| Cataract |
2.5% |
| Chest Pain |
2.5% |
| Cough |
2.5% |
| Drug Exposure During Pregnancy |
2.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
25.1% |
| Asthma |
19.4% |
| Drug Use For Unknown Indication |
13.7% |
| Hypersensitivity |
5.8% |
| Hypertension |
4.1% |
| Gastrooesophageal Reflux Disease |
3.4% |
| Pain |
3.4% |
| Contraception |
2.7% |
| Rheumatoid Arthritis |
2.5% |
| Depression |
2.4% |
| Migraine |
2.2% |
| Seasonal Allergy |
2.0% |
| Multiple Allergies |
1.8% |
| Vitamin Supplementation |
1.8% |
| Hypothyroidism |
1.8% |
| Prophylaxis |
1.7% |
| Rhinitis Allergic |
1.7% |
| Chronic Obstructive Pulmonary Disease |
1.6% |
| Diabetes Mellitus |
1.5% |
| Nausea |
1.5% |
|
| Weight Increased |
9.6% |
| Pulmonary Embolism |
8.3% |
| Throat Tightness |
7.3% |
| Pain |
6.9% |
| Sinusitis |
6.9% |
| Suicidal Ideation |
6.4% |
| Product Quality Issue |
6.0% |
| Deep Vein Thrombosis |
5.0% |
| Drug Ineffective |
4.6% |
| Dyspnoea |
4.6% |
| Nausea |
4.1% |
| Rash |
4.1% |
| Weight Decreased |
4.1% |
| Vomiting |
3.7% |
| Anaphylactic Reaction |
3.2% |
| Depression |
3.2% |
| Pneumonia |
3.2% |
| Wheezing |
3.2% |
| Chest Pain |
2.8% |
| Gastrointestinal Haemorrhage |
2.8% |
|
